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Abstract Plastics are highly versatile materials that have brought huge  societal 
benefits. They can be manufactured at low cost and their lightweight and 
adaptable nature has a myriad of applications in all aspects of everyday life, 
 including food packaging, consumer products, medical devices and construction. 
By 2050, however, it is anticipated that an extra 33 billion tonnes of plastic will 
be added to the planet. Given that most currently used plastic polymers are highly 
resistant to degradation, this influx of persistent, complex materials is a risk to 
human and environmental health. Continuous daily interaction with plastic items 
allows oral, dermal and inhalation exposure to chemical components, leading to 
the widespread presence in the human body of chemicals associated with plas-
tics. Indiscriminate disposal places a huge burden on waste management systems, 
allowing plastic wastes to infiltrate ecosystems, with the potential to contaminate 
the food chain. Of particular concern has been the reported presence of micro-
scopic plastic debris, or microplastics (debris ≤1 mm in size), in aquatic, terres-
trial and marine habitats. Yet, the potential for microplastics and nanoplastics of 
environmental origin to cause harm to human health remains understudied. In this 
article, some of the most widely encountered plastics in everyday use are identi-
fied and their potential hazards listed. Different routes of exposure to human popu-
lations, both of plastic additives, microplastics and nanoplastics from food items 
and from discarded debris are discussed. Risks associated with plastics and addi-
tives considered to be of most concern for human health are identified. Finally, 
some recent developments in delivering a new generation of safer, more sustain-
able polymers are considered.
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If a visitor from 50 years ago were to turn up today, one of the first things he 
would notice (other than how much heavier we all were), would be how much 
plastic there is everywhere. We use plastics to wrap our food, we drink from 
 plastic containers, cook with plastic utensils, deliver drugs to patients through 
plastic tubing. We increasingly use plastics and polymer composites in construc-
tion. Worldwide annual production of plastics is estimated to be in the region of 
300 million tonnes. Plastic demand in the European Union alone for 2010 was 
estimated at 46.4 million tonnes, consisting of two main types: plastics used for 
packaging of food and consumer items, with the second group constituting plastics 
used in the construction industry (PlasticsEurope 2013). With overall recycling 
rates at around 57.9 %, this corresponds to around 24.7 million tonnes of plas-
tic debris entering the waste stream each year. Waste disposal includes littering, 
land fill and the sewerage system and ultimately, a significant proportion of plastic 
waste ends up in the sea. Jambeck et al. (2015) estimated that 4.8 to 12.7 million 
tonnes of plastic waste entered the ocean in 2010.
Whilst these figures are alarming in terms of volume, it is not yet clear how this 
large scale and ubiquitous use affects human health. As an example, some 14.5 million 
tonnes per annum of plastic is used in the food packaging industry alone (European 
Plastics Converters). On the positive side, improvements in food packaging can pre-
vent bacterial infections, such as Salmonella and other food borne disease (Hanning 
et al. 2009; European Commission 2014), and can prevent wastage and aid distribu-
tion. Conversely, migration of contaminants from food packaging into food is consid-
ered the main route of exposure of human populations to contaminants associated with 
plastics (Grob et al. 2006), with only a small fraction of the thousands of substances 
that may be present having been subject to extensive testing (Claudio 2012). Whilst 
rigorous standards are in place to regulate food-contact substances in terms of migra-
tion into food (EFSA 2011), it is less clear how these guidelines offer protection once 
the plastics themselves have been discarded to the environment. With only limited 
information available about rates of degradation and fragmentation, leaching of chemi-
cals into environmental matrices, and entry into the food chain, it is almost  impossible 
to estimate the cumulative risks of chronic exposure to plastics and their additives.
One way around this problem is to determine what chemicals are actually pre-
sent in the human body. Human biomonitoring involves measuring the concen-
trations of environmental contaminants and/or their metabolites in human tissues 
or body fluids, such as blood, breast milk, saliva or urine. Biomonitoring is con-
sidered a gold standard in assessing the health risks of environmental exposures 
because it can provide an integrated measure of an individual’s exposure to con-
taminants from multiple sources (Sexton et al. 2004). This approach has shown 
that chemicals used in the manufacture of plastics are certainly present in the 
human population. For some chemicals, their widespread presence in the general 
population at concentrations capable of causing harm in animal models has raised 
public health concerns (Talsness et al. 2009; Melzer and Galloway 2010). The 
National Health and Nutrition Examination Survey (NHANES) is a program of 
345
studies designed to assess the health and nutritional status of adults and children 
in the United States and represents one of the most comprehensive human bio-
monitoring programs yet undertaken (http://www.cdc.gov/nchs/nhanes.htm). Of 
interest for this article, NHANES reports on several chemicals associated with the 
use or production of plastics, including bisphenol A, phthalates, styrene, acryla-
mide, triclosan and brominated flame retardants, and their concentrations in the 
general population.
This review considers the kinds of plastics in widespread, everyday use and 
the potential hazards they may cause. It reviews the routes of uptake of micro and 
nanoplastics into humans through the food chain and the potential consequences 
for human health. Health risks associated with microplastics and plastic-associated 
chemicals are discussed. Lastly, some new developments in alternative low toxic-
ity polymers and novel nanocomposite materials are described and their potential 
benefits to human health discussed.
13.2  What Kinds of Plastics Are in Use?
The term plastic is used to describe plastic polymers, to which various additives 
are added to give desirable properties to the final product (OECD 2004). The 
demand for plastics in Europe alone is estimated to be 45.9 million tonnes in 
2012 (PlasticsEurope 2013), with plastics demand by industry segment shown 
in Table 13.1. As can be seen, packaging, which includes food and  beverage 
 packaging, is the single largest category by a considerable margin. Plastics 
are generally divided into two types: thermoplastic, which soften on heating 
and can be remoulded, and thermosetting, in which case cross-linking in the 
 polymers means they cannot be re-softened and remoulded. With reference to 
these properties, plastics can be further classified into seven different groupings 
based on their ease of recycling. Table 13.2 lists some examples of products made 
from these seven different plastics groups and the demand for different resin and 
polymer types based on this classification system (for Europe). As can be seen, the 
Table 13.1  Plastics demand by industry segment in Europe, 2012
Figures are derived from PlasticsEurope (2013)
Industry segment Volume (millions of tonnes) Percentage of total
Packaging 18.1 39.4
Building and construction 9.32 20.3
Automative 3.76 8.2
Electronics and electrical 3.03 6.6
Agriculture 1.93 4.2
Other (furniture, health and safety, sport, 
consumer and household appliances, etc.)
10.3 22.4
Total (demand for 2012) 45.9 100.0
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main classification group (code 7) makes up 19.8 % of total European demand, yet 
has a 0 % recycling rate. The second most commonly used plastic, polypropylene 
(18.8 % of demand), has a 1 % recycling rate.
13.3  Plastics and Human Health
Plastic polymers are generally considered to be inert and of low concern to human 
health, and health risks relating to their use are attributed to the presence of the 
wide range of plastic additives they may contain, together with residual monomers 
that may be retained within the polymer structure (Araujo et al. 2002). Plastics are 
 synthesised from monomers, which are polymerised to form macromolecular chains. 
A range of additional chemicals may be added during the manufacturing process, 
including initiators, catalysts and solvents. Additives that can alter the nature of the 
Table 13.2  European plastic demand by resin type
Figures are for 2012 and are derived from PlasticsEurope (2013). aRecycling figures derived 
from Engler (2012)
Code Resin type Example product Volume of 
demand (millions 
of tonnes)





1 PET polyethylene 
terephthalate
Soft drink bottle, 
polyester fibre
2.98 6.5 20
2 PE-HD polyethylene 
high density
Plastic bottle, plastic 
bag, bottle cap
5.51 12.0 11
3 PVC polyvinyl  
chloride
Water proof boot,  
window frame,  
plumbing pipe
4.91 10.7 0
4 PE-LD polyethylene 
low density
Wire cable,  
plastic bag,  
bucket, soap  
dispenser bottle,  
plastic tube
8.03 17.5 6
5 PP polypropylene Stationary folder,  
plant pot, bags, indus-
trial fibre
8.63 18.8 1
6 PS. PSE polystyrene Food container,  
plastic cup, glasses  
frame, car bumper
3.40 7.4 1







Drink bottle, consumer 
item, clothing,  
medical equipment
9.82 19.8 0
Total 45.9 100.0 39
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final plastic include stabilisers, plasticisers, flame retardants, pigments and fillers. 
Additives are not bound to the polymer matrix and because of their low molecular 
weight, these substances can leach out of the plastic polymer (Crompton 2007) into 
the surrounding environment, including into air, water, food or body tissues.
There are thousands of additives in routine use in the synthesis of plastic prod-
ucts. As comprehensively reviewed by Lithner et al. (2011), certain plastics types 
typically contain more additives than other types. Polyvinylchloride (PVC) is the 
polymer associated with the use of most additives, including heat stabilisers to keep 
the polymer stable during production, and plasticisers such as phthalates to allow 
flexibility (Lithner et al. 2011). Plasticisers may constitute a high percentage (up 
to 80 %) of the weight of the final product (Buchta et al. 2005). Polypropylene is 
highly sensitive to oxidation and typically contains significant amounts of anti-
oxidants and UV stabilisers (Zweifel 2001). Other chemicals that may leach from 
plastics include nonylphenol from polyolefins, brominated flame retardants from 
acrylonitrile-butadienestyrene (ABS) or urethane foam and bisphenol A (BPA) from 
polycarbonate. The rate at which these substances are released from the product is 
governed by many factors, including the size and volatility of the additive, the per-
meability of the polymer itself (migration is greater for highly permeable polymers), 
and the temperature and pH of the surrounding medium (air, water, soil, body tis-
sues) (Zweifel 2001).
Plastics may also pose a hazard due to the release of the constituent monomers 
themselves (Lithner et al. 2011). Most of the plastics in everyday use are highly 
resistant to microbial degradation. Instead, degradation and release of polymers 
is ultimately caused by exposure to abiotic factors such as ultraviolet (UV) light, 
heat, mechanical and/or chemical abrasion (Andrady 2015). Breaking of the chem-
ical bonds in the polymer backbone leads to chain scission and depolymerisation; 
chain stripping occurs when side chains are broken and released. All of these pro-
cesses proceed at different rates under different environmental conditions, e.g. 
variations in temperature and oxygen, and proceed at different rates for differ-
ent polymer types, with polyesters, polycarbonate and polyurethane more prone 
to depolymerisation for example than polyethylene or polypropylene (Nicholson 
1996; La Mantia 2002). It is therefore extremely difficult to predict the risks asso-
ciated with exposure to plastics and their additives, given the vast complexity and 
variability of the available product combinations, their varied uses and eventual 
environmental distribution once discarded.
Lithner et al. (2011) addressed this complex problem by conducting a 
 comprehensive hazard ranking of plastic polymers based on their chemical com-
position. They studied 55 of the most widely used polymer types with global 
production volumes of >10,000 tonnes per year. A model for ranking the hazard 
of each polymer was developed by ranking the constituent monomer chemicals 
according to internationally agreed criteria for identifying physical, environ-
ment and health risks. The polymer types that received the highest and the low-
est hazard rankings according to this criteria are shown in Table 13.3. Table 13.4 
shows the ranking for polymer types commonly reported in plastic and micro-
plastic litter.
348 T.S. Galloway
Table 13.3  Ranking of some plastic polymer types based on hazard classification of constituent 
monomers, adapted from Lithner et al. (2011)








Polymers with the highest relative hazard scores
Polyurethane PUR as a 
flexible foam










With plasticiser 10,551 3 Benzyl butyl 
phthalate 
(BBP)
Benzyl butyl phthalate 




Polyurethane, PUR as a 
rigid foam
















Styrene 2788 7 Styrene
Acrylonitrile
High impact polystyrene 
HIPS
Styrene 1628 Styrene









Terephthalic acid 4 1
Polyvinyl acetate PVA Vinyl acetate 1
Polypropylene PP Propylene 1 5
aRelative hazard score derived from different constituent monomers. Higher ranking = greater 
hazard
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As noted by the authors, the hazard ranking does not imply that the polymers 
themselves are hazardous, but rather that release of hazardous substances or deg-
radation products may occur during the product lifecycle, i.e. from production 
through use of the product and its eventual discard to waste or into the environ-
ment. From this point of view, Table 13.3 also identifies polymers that may con-
tain compounds that are currently the subject of biomonitoring activities under 
the NHANES program. Note that NHANES also monitors compounds that may 
be present in multiple, diverse items including many different types of plastics 
and plastics products, such as the microbial agent triclosan and the UV screen and 
printing ink additive benzophenone.
The polymers ranked as most hazardous were those produced from monomers 
classified as carcinogenic, mutagenic or both, leading to high hazard rankings for 
polyurethanes, polyvinylchloride, epoxy resins and styrenic polymers. One limita-
tion of this approach noted by the authors was the lack of available chemical safety 
data for many of the substances they were considering. In particular, there was 
no hazard class available for chemicals suspected of being endocrine disruptors, 
including bisphenol A, phthalates, and epichlorohydrin. This toxicity endpoint was 
therefore not included in the hazard assessment. This represents a major limita-
tion in our current ability to predict the risks associated with plastics associated 
chemicals, since so many of these are recognised to have endocrine disrupting abil-
ities (Koch and Calafat 2009). Despite these limitations, this study represents an 
extremely useful attempt to identify those polymer types that could be a cause for 
concern due to the environmental and health effects of their constituent monomers.
13.4  Micro- and Nanoplastics
13.4.1  Occurrence of Micro- and Nanoplastics  
in the Environment
In addition to larger items of plastic litter, concern has been raised that micro-
scopic plastic debris (microplastic) (<1 mm) may also be detrimental to the 
environment and to human health (Thompson et al. 2004; Cole et al. 2011). 
Table 13.4  Plastics identified in microplastic debris and their relative hazard ranking
aRelative hazard score derived from different constituent monomers. Higher ranking = greater 
hazard
Adapted from Hidalgo-Ruz et al. (2012) and Lithner et al. (2011)
Polymer type Density g/cm3 Relative hazard scorea




polyethylene teraphthalate 1.37–1.45 4
Polyvinylchloride 1.16–1.58 10,551–5001
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Microplastics have been studied mostly in the context of the marine environment, 
and have been found to be a major constituent of anthropogenic marine debris. 
They consist of small plastic items, such as exfoliates in cosmetics, or fragments 
from larger plastic debris, including polyester fibres from fabrics, polyethyl-
ene fragments from plastic bags and polystyrene particles from buoys and floats 
(reviewed by Cole et al. 2011).
There is sparse information available on the presence of microplastics in 
environments other than the oceans, for example in terrestrial soils or freshwa-
ter environments. The presence of microplastic particles (Dubaish and Liebezeit 
2013) and synthetic polymer fibres (Zubris and Richards 2005) has been reported 
in sewage sludge and in the soils to which they had been applied (Zubris and 
Richards 2005), where they were still detectable five years after application. A 
study of surface waters in the southern North Sea found microplastics and micro-
fibres in all of the samples that were tested, with an increasing gradient towards 
land sources (Dubaish and Leibezeit 2013). Browne et al. (2011) showed that 
the polyester and acrylic fibres used in clothing closely resembled those found in 
coastal sediments that receive sewage discharges, suggesting that sewage effluents 
represent a significant source of microfibres from the washing of clothes, and that 
these are not wholly retained during wastewater treatment.
A study of beach sediments around Lake Garda, a subalpine lake in Italy, found 
microplastics at abundances of up to 1108 ± 983 microplastic particles/m2 (Imhof 
et al. 2013), which is similar to the contamination levels reported for the Great Lakes 
in the USA (Zbyszewski and Corcoran 2011). These levels of contamination most 
likely originate from landfill, litter and wastewater sources, and are within the range 
of values reported for the abundance of plastic particles found in marine coastal sedi-
ments (0.21–77,000 particles/m2), albeit at the lower end of exposures (Hidalgo-Ruz 
et al. 2012). This does, however, indicate that microplastics are present in both agri-
cultural soils and freshwater sites. Knowledge on the occurrence of nanoplastics in 
aquatic environments and biota is extremely limited because no methods exist for the 
reliable detection of nanoplastics in samples (Koelmans et al. 2015).
13.4.2  Micro- and Nanoplastics and Human Health
In terms of human health risks, microplastics as contaminants in the wider environ-
ment represent a concern because it has been shown that they can be ingested by 
a wide range of aquatic organisms, both marine and freshwater, and thus have the 
potential to accumulate through the food chain. Aquatic organisms for which inges-
tion of microplastics has been documented in the field include those from across the 
marine food web, including turtles, seabirds, fish, crustaceans and worms (reviewed 
by Wright et al. 2013). Laboratory studies have confirmed that many other organ-
isms have the capacity to ingest microplastics including zooplankton (Cole et al. 
2013; Setälä et al. 2012). The majority of studies have documented microplastics in 
the guts of organisms, an organ that is not generally consumed directly by humans. 
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Exceptions to this include shellfish such as mussels, clams and some shrimps that 
are eaten whole or with their gut. The risk of ingesting microplastics contained 
within other tissues depends on the degree to which uptake of microplastics and 
translocation and redistribution and retention within other body tissues occurs. This 
concept is discussed further below, in relation to human ingestion.
In addition to the potential for ingestion to cause adverse biological effects due 
to gut blockages and/or damage, or the reduction in energy assimilation (Wright 
et al. 2013), the large surface area of microplastics means that environmental pollut-
ants may sorb to the surface of the particles, with the potential to be transferred into 
body tissues once ingested. For a more comprehensive coverage of the uptake of 
microplastics by wildlife organisms, and the transfer to tissues of hydrophobic pol-
lutants adsorbed from the surrounding environment, the reader is referred to excel-
lent recent reviews (e.g. Engler 2012) and to other chapters in this issue (Koelmans 
2015; Lusher 2015). Despite this concern, there is currently no available information 
to evidence the uptake or biological effects of microplastics originating from marine 
or terrestrial debris and subsequently ingested by humans through the food chain.
13.4.3  Ingestion of Micro- and Nanoplastics  
and Uptake Across the Gut
Whilst the potential clearly exists for microplastics to be present in food items, 
there is currently no evidence for the unintentional ingestion or subsequent trans-
location and uptake of microplastics into the human body through the diet. There 
is, however, a huge interest worldwide in the use of micro- and nanospheres as 
pharmaceutical drug delivery systems through oral, intravenous and transcutane-
ous routes (Kim et al. 2010), and in the migration of nanopolymers from packag-
ing materials into food (EFSA 2011; Lagaron and Lopez-Rubio 2011). Based on 
these growing and fast moving fields, an enhanced understanding of the mecha-
nistic pathways by which micro- and nanoparticles could enter the human body 
is starting to emerge, although many aspects of this field remain to be elucidated.
Following oral ingestion, the gut mucosa represents an important barrier, which 
has evolved to allow efficient uptake of nutritious items, whilst excluding poten-
tially harmful substances or organisms. Significant uptake of microplastics into the 
body through this route is in theory then limited to particles that can enter the body 
through exploitation of existing routes. Following oral ingestion, uptake of inert 
particles across the gut has been widely studied (O’Hagan 1996). The ‘persorption’ 
of starch particles as large as 150 μm through the tips of the villi was described in 
detail by Volkheimer (1977). According to his observations, persorption of particles 
can occur as a passive process in areas of the gut where the intestinal mucosa is 
covered by a single layer of epithelium. Persorbed particles were detectable in the 
lumen of blood and lymph vessels within minutes, and were eventually eliminated 
in the urine, confirming that the translocation of relatively large, inert particles 
from the gut to other body fluids is possible (Volkheimer 1977).
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Aside from this observation, digestive absorption of smaller particles proceeds 
through pinocytosis and vesicular phagocytic processes for materials in the nano 
and micron range. Particle size is one of the most important factors in determin-
ing the extent and pathway of uptake. Smaller particles are generally favoured 
over larger ones. For example, polystyrene microspheres of 50–100 nm were more 
readily absorbed across the Peyer’s patches and the villi of the gut than larger 
 particles of 300–3000 nm (Jani et al. 1992; Florence and Hussain 2001). On the 
other hand, the uptake of ultrafine polylysine dendrimers of 2.5 nm was lower than 
that of larger polystyrene particles of 100 nm–3 µm, suggesting that size is not the 
only deciding factor (Florence et al. 2000). Indeed, a combination of size, surface 
charge and hydrophilicity all contribute to uptake affinity (as discussed by Awaad 
et al. 2012). The predominant site of uptake for micron-scale particles in the gut 
is reported to be through gut-associated lymphatic tissue (GALT), specifically by 
the Microfold (M) cells of the Peyer’s patches. M cells are specialised epithelial 
cells that lack the microvilli found on other gut epithelial cells and instead have 
broader (micro)folds and a thinner luminal surface that allows them to actively take 
up particulate matter from the intestine. The reported efficiency of this uptake var-
ies depending on the study method, species and particle type. Uptake of polystyrene 
microspheres through the gut by this route was higher in species such as rabbits, 
which have a high abundance of M cells (Pappo et al. 1989), and was enhanced 
when food was also present, probably due to the delayed transit time through the 
gut (Ebel 1990). As an alternative route, uptake by enterocytes appears to be lim-
ited to a size range of around 100 nm (Jani et al. 1992). Awaad et al. (2012) used 
fluorescent organosilica particles, histological examination and quantitative analysis 
to confirm an optimal size range of around 100 nm for uptake of particles through 
the M cells of the Peyer’s patches, with smaller and larger particles less likely to 
be taken up. They also identified two alternative uptake pathways by which nano-
particles passed between (paracellular-E uptake) or through (transcellular-E uptake) 
enterocytes in the Peyer’s patches. These two pathways have previously been 
described as major mechanisms for larger particles of >1 µm outside of the Peyer’s 
patches (Kreuter 1991), but had not previously been described in relation to nano-
particle uptake by the Peyer’s patches.
Garrett et al. (2012) used a novel bio-imaging technique, multimodal non-
linear optical microscopy, to document uptake of polymeric nanoparticles by 
enterocytes in the mouse gut in vivo. They studied a novel amphipathic polymer 
specifically designed for drug delivery, ammonium palmitoyl glycol chitosan 
(GCPQ) of 30–50 nm in diameter and showed that after uptake by enterocytes, 
particles accumulated at the base of the villi. From there, they passed into the 
blood stream and were transported to the liver, where they were detectable in 
the hepatocytes and intracellular spaces, before recirculating through the bile to 
the small intestine (Garrett et al. 2012) to be excreted with faecal matter. This 
is  similar to previous results for larger micron-scale polystyrene and latex parti-
cles, suggesting that both micron and nano-scale polymers are treated in a similar 
manner (Jani et al. 1996), with uptake across the gut, recirculation and eventual 
elimination through faecal matter and urine (Fig. 13.1).















Fig. 13.1  A diagram illustrating a proposed recirculation pathway for polymer nanoparticles 
(ammonium palmitoyl glycol chitosan) after oral administration. The nanoparticles are taken up into 
the blood from the gut through M cells, and from there through the lymphatic system (shown in yel-
low) and into the liver and gall bladder. Particles are then re-released into the gut together with bile 
(shown in green) before excretion in faeces and urine. Adapted from Garrett et al. (2012)
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This information is of high interest in terms of drug delivery, yet it also sug-
gests that ample opportunity exists, following ingestion, for micro- and nanoplas-
tics in food or water to enter, circulate and bioaccumulate within the body.
13.4.4  Interaction of Microspheres and Nanoparticles  
with Cells and Tissues
The behaviour of nano- and microplastics after they have entered the circulation 
from the gut is not fully understood, but has been the subject of study in relation 
to food packaging materials and nanomedicines. Certainly, in vivo behaviour will 
be dependent on numerous factors, such as the physico-chemical properties of 
the particles (size, surface charge, aspect ratio, porosity, surface corona) and the 
physiological state of the individual. Risk assessments of manufactured nanomate-
rials including titanium dioxide (Wang et al. 2007) and carbon (Poland et al. 2008) 
have shown comparable results to those shown above for nanopolymers, with 
uptake across the gut into the circulation and redistribution to the liver and spleen. 
Circulation time is highly dependent on the surface characteristics of the particle, 
with hydrophilic and positively charged particles showing enhanced circulation 
times (Silvestre et al. 2011).
13.4.5  Interactions with Biological Materials and Cells
Interaction of nanopolymers with cells and tissues has again been the subject of 
intensive study. Because of their surface properties, nanopolymers are predicted 
to adsorb macromolecules such as proteins and lipids from the surrounding body 
fluids onto their surface, in a process influenced by surface energy, charge and spe-
cific affinity for certain biomolecules. The resulting ‘corona’ will then influence 
the resulting behaviour and toxicity of the particle (Lundqvist et al. 2008; Tenzer 
et al. 2013). This process has been extensively studied for polymers intended for 
therapeutic use particularly using polystyrene as a model polymer, but little or 
nothing is known of how protein coronas may form on the types of polymers most 
commonly found in environmental debris.
The results from mechanistic studies of different types of particle show that 
the potential for cytotoxicity of circulating particles in vivo to cells and tissues is 
related to many factors, including size, shape, solubility, surface charge, surface 
reactivity and energy band structure (Nel et al. 2006; Burello and Worth 2011). 
For example, it would be reasonable to hypothesize that particles with a high 
abundance of reactive surface groups would be capable of denaturing surround-
ing lipids and proteins. As an illustration of this, the toxicity of silica nanoparti-
cles in vivo was attributed to proton donating silanol groups on the surface of the 
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particles, leading to denaturation of membrane proteins and subsequent membrane 
damage. In this case, the reactivity of the surface hydrogen of silica bonds with 
membrane proteins led to their abstraction from the membrane, with subsequent 
membrane damage and distortion leading to haemolytic symptoms following 
exposure (Pandurangi et al. 1990).
Surface charge is also a strong attributing factor for toxicity (Geys et al. 2008). 
In inhalation studies in rats, the toxicity of acrylic ester nanopolymers in the size 
range 50–1500 nm was found to be low, and this was attributed to their anionic 
surface charge (Ma-Hock et al. 2012). Studies in which the surface charge of 
stearylamine-polylactic acid (PLA) polymers was modified from positive to nega-
tive showed that cationic particles showed higher pulmonary toxicity (Harush-
Frenkel et al. 2010). This was attributed both to a higher localisation of cationic 
particles in the lung and to enhanced cellular uptake. Overall, the interaction of 
cationic polymers with the negatively charged cell surface has been proposed as a 
cause of their higher cytotoxicity (Fischer et al. 2003).
Translocation of nanopolymers into diverse tissues and cell types presents 
another point at which toxicity may occur. Translocation is dependent on inter-
actions with the cell membrane and is most likely to proceed, as for uptake by 
enterocytes in the gut, through pinocytic, phagocytic and receptor-mediated 
endocytosis (Fruijter-Polloth 2012). A study, which measured the uptake rates of 
individual polystyrene microspheres into human astrocytes and lung carcinoma 
cells in culture found that the uptake rate differed for particles of different sizes, 
implying that there are differences in the mechanisms involved. Particles with a 
diameter of 40 nm showed higher uptake rates than either 20 or 100 nm particles. 
Since the van der Waals force between a sphere and a surface is proportional to the 
diameter of the sphere (Israelachvili 1992), it could be predicted that larger parti-
cles would be taken up faster. The conclusion was that the endocytic mechanism 
for internalisation of 40 nm particles exhibited faster kinetics, providing a privi-
leged size gap for 40 nm particles (Varela et al. 2012).
Phagosomes containing particles may fuse with endosomes following inter-
nalisation, leading to accumulation of particles in lysosomes. Depending on the 
dose and type of particle, this has the potential to overwhelm lysosomal  capacity 
and interfere with programmed cell death and pathways of cellular breakdown of 
pathogens (Fruijter-Polloth 2012). The numerous additional modes of toxicity that 
may result are again dependent on particle and cell type, and include the poten-
tial for oxidative damage, inflammation and accumulation in diverse tissue types 
(Silvestre et al. 2011; Nel et al. 2006, 2009). In theory, all organs may be at risk 
following chronic exposure to nanopolymers, including the brain, testis and repro-
ductive organs, prior to their eventual excretion in urine and faeces (Jani et al. 1996; 
Garrett et al. 2012). Distribution to the foetus in utero is also a possibility that 
cannot be excluded. Given the long-term persistence of many polymer types, more 
research is required to adequately assess the risks that accumulation of micro- and 
nanoplastics in the body may pose.
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13.5  Assessing the Risks that Micro- and Nanoplastics  
Pose to Human Health
13.5.1  Leaching of Toxic Chemicals from Plastics
As discussed previously, plastics can contain complex mixtures of additives to 
enhance their physical properties, which can leach from the polymer into the sur-
rounding milieu. Leaching will occur primarily at the surface of the plastic par-
ticle, with the possibility of constant diffusion of chemicals from the core of the 
particle to the surface. Thus, leaching from plastic particles could present a long-
term source of chemicals into tissues and body fluids, despite the fact that many 
of these chemicals are not persistent and have short half lives in the body (Engler 
2012). Plastics additives of concern to human health include phthalates, bisphenol 
A, brominated flame retardants, triclosan, bisphenone and organotins.
The potential migration of polymer constituents and additives into food and 
drinks is considered to be a major route of exposure of the human population 
and as might be expected is subject to extensive legislation. The measurement 
of migration levels is typically estimated from measurements using different sol-
vents to simulate the receiving environment (e.g. foodstuffs), or can be estimated 
using partitioning models that consider aspects including the desportion rates from 
the polymers, dimensions of the polymer framework and dimensions of the dif-
fusing molecules (Helmroth et al. 2002). The European Food Standards Agency 
has a total migration limit of 10 mg/dm2 for additives within plastics intended for 
packaging use, with a more stringent migration limit of 0.01 mg/kg for certain 
chemicals of concern (Commission Directive 2007/19/CE that modifies Directive 
2002/72/CE). This means that for an average 60 kg adult who consumes 3 kg of 
foods and liquids per day, exposures to individual substances from food packaging 
could be up to 250 μg/kg body weight per day (Muncke 2011).
13.5.2  Bisphenol a and Human Health
There is very little information on the leaching of additives into biological tissues 
directly, but one chemical monomer that has received considerable attention in rela-
tion to its human health effects is bisphenol A (Fig. 13.2). Bisphenol A (BPA) was 
first synthesised in the 1930s as a synthetic estrogen (Dodds and Lawson 1936) and 
is now a high-production volume chemical used as a monomer in the production of 
polycarbonate plastic and in the epoxy resins lining food and beverage cans. There 
are numerous studies showing that BPA can migrate out of polycarbonate (reviewed 
Fig. 13.2  Bisphenol A CH3
CH3
OHHO
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in Guart et al. 2013) and contaminate foodstuffs and drinks, and oral ingestion 
is considered the major route of exposure of the human population (Calafat et al 
2008). Additional routes of exposure are predicted from the inhalation of household 
dusts and dermal uptake from printed materials (Ehrlich et al. 2014). BPA undoubt-
edly enters the human body, with studies showing exposure of >95 % of popula-
tions in USA, Europe and Asia (Galloway et al. 2010; Vandenberg et al. 2010).
Bisphenol A exerts its biological activity predominantly through interaction with 
steroid hormone receptors, showing both estrogenic and antiandrogenic activity and 
suppressing aromatase activity (Bonefeld-Jørgensen et al. 2007, Lee et al 2003). 
Additional receptor-mediated effects reported in various model systems include 
binding to the orphan estrogen-related receptor ERRα (Okada et al. 2008), thyroid 
hormone disruption (Moriyama et al. 2002), altered pancreatic beta cell function 
(Ropero et al. 2008) and obesity promoting effects (Newbold et al. 2008). There 
is growing evidence from epidemiological and laboratory studies that exposure to 
BPA at levels found in the general population, around 0.2–20 ng/ml (values given 
for urinary BPA), is associated with adverse human health effects, including the 
onset of obesity and cardiovascular disease (Lang et al. 2008; Melzer et al. 2010, 
2012; Cipelli et al. 2013) and with numerous reproductive and developmental out-
comes. These include increases in abnormal penile/urethra development in males, 
an increase in hormonally-mediated cancers including breast and prostate cancers, 
neurobehavioural disorders including autism and early sexual maturation in females 
(reviewed by vom Saal et al. 2007; Hengstler et al. 2011; Rochester 2013).
Whether the release of BPA from ingested micro- or nanoplastics directly into 
the body contributes to human exposure remains unknown. The current tolerable 
daily intake is 0.05 mg/kg/day (EFSA 2006) and compared with this, the median 
exposure of the general adult population globally has been estimated from human 
biomonitoring or urinary BPA to be 0.01–0.12 μg/kg/day (EFSA 2015). The 
 concentrations of BPA in plasma are higher than would be predicted only from 
this level of exposure to BPA through food and drink (Mielke and Gundert-Remy 
2009), and it is therefore plausible that other routes of exposure could occur, e.g. 
from ingestion of plastic particles containing BPA, which subsequently leaches 
into tissues. BPA can certainly be absorbed across body surfaces other than the 
gut. Gayrard et al. (2013) showed that BPA can be absorbed with relatively high 
 efficiency sublingually, an effect likely enhanced by its low molecular weight and 
moderate water solubility, allowing it to penetrate the sublingual membrane.
There are no studies in humans of the transfer of BPA from plastic directly 
into tissues, but the potential for BPA to leach from ingested polycarbonate into 
aquatic species was explored by Koelmans et al. (2014) who used biodynamic 
modeling to calculate the relative contribution of plastic ingestion to total expo-
sure to chemicals residing in the ingested plastic. They estimated plastic:lipid 
exchange coefficients for a range of plastic particle sizes for two species, fish and 
sediment-dwelling worms. They proposed that a continuous ingestion of plastic 
containing 100 mg/kg BPA would lead to a very low steady-state concentration of 
0.044 ng/kg BPA in fish and 60 μg/kg (normalized to lipid) in worms. Whilst this 
represents a substantial exposure pathway, the risk of exposure through this route 
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was considered low in comparison with other pathways of exposure, based on the 
reported abundance of microplastics.
13.5.3  Safer Alternatives to BPA
Concern over exposure to BPA and its potential to cause harmful effects has led 
to worldwide efforts to formulate alternative polymer materials. This is a techni-
cally challenging area, largely because polycarbonate is such a useful material. It 
is an optically clear, strong and heat resistant plastic and hence has a wide range of 
uses. One promising formulation is a copolyester called TritanTM, which contains 
three different monomers, dimethyl terephthalate, cyclohexane dimethanol and 
tetramethyl cyclobutanediol (Eastman 2010). Studies have shown that it has a low 
migration potential, both for its constituent monomers and for the additives that 
are present in the polymer matrix. More importantly, the constituents and the lea-
cheates from the polymer showed neither hormonal nor toxic activity. In a study 
by Guart et al. (2013), the leacheate from TritanTM and from polycarbonate bot-
tles into water was collected and tested in a number of in vitro bioassays, includ-
ing for estrogenic, (anti) androgenic activity and for retinoic acid and vitamin D 
type activities. The TritanTM leacheates showed no activity at any concentration, 
whereas the leacheate from polycarbonate showed estrogenic and antiandrogenic 
activity at higher concentrations (Guart et al. 2013). These findings are interesting, 
as they show the potential for newer, safer polymer alternatives to reduce unin-
tended exposure of the human population.
13.5.4  Novel Polymer Formulations
In assessing the physical risks posed by ingestion of nano- or microplastics that 
unintentionally enter the food chain, much information and guidance can be 
gained from existing risk assessments performed for food packaging. For exam-
ple, the European Food Safety Authority (EFSA) has produced detailed guidance 
for assessing the risks of exposure to nanomaterials, including nanocomposites, 
biopolymers and other complex materials, from their applications in the food 
chain (EFSA 2011). As detailed by EFSA, there are huge uncertainties that are 
associated with detecting, identifying and characterising different micro-, and nan-
oparticles and polymers in complex matrices such as food, even when the likely 
constituent substances are known, and these problems are multiplied where rates 
and sources of contamination remain unknown. In general, however, the consid-
erations suggested by EFSA provide a useful framework applicable to the risks 
posed by microplastics and nanoplastics as contaminants in food.
Based on the guidance provided by EFSA, it can be predicted that the risks 
posed by micro- or nanopolymers to human health will be determined by the 
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chemical composition and physico-chemical properties of the particles them-
selves, their potential for uptake and interactions with tissues, and the likely 
potential exposure levels. Actual information on migration rates of nanoparticles 
into food or food stimulants is sparse. Simon et al. (2008) derived a theoretical 
model to estimate migration rates of nanoparticles from a polymer matrix. The 
model predicted that migration from polymers of low dynamic viscosity would 
be limited to particles of <1 nm in diameter, even where the interaction between 
particle and polymer was negligible. These estimates are in accord with results 
from Schmidt et al. (2009) who used a combination of field flow fractionation 
and analytical chemistry techniques to study the migration of nanoparticles out of 
polylactic acid (PLA). Whilst migration out of the matrix did definitely occur, the 
resulting nanoparticle concentrations were well below the recommended migra-
tion limits. Migration may also be higher into acidic matrices (Mauricio-Inglesias 
et al. 2010). Table 13.5 compiles some of the indicators identified by EFSA to 
have the potential to lead to toxicity following uptake of nanoparticles in the diet. 
These include high levels of reactivity, complex morphologies, the ability to inter-
act with biomolecules, stability and presence of toxic additives. Accordingly, one 
might expect the greatest hazard to human health to come from ingestion of com-
plex, high aspect ratio nano-scale fibres, synthesised from mixed substances of 
variable persistence.
13.5.5  Nanopolymers and Nanofillers
There are many technological advances in the development of complex bio-
composites and nanopolymers that are relevant for consideration here. 
Nanocomposites are complex macromolecular materials containing small quanti-
ties of nanoscale additives, or nanofillers. The most commonly employed nano-
fillers for food packaging (the most common type of plastic litter) are nanoclays. 
Other common nanofillers include nanocellulose fibres, carbon nanotubes, metals 
and oxides. Nanofillers are intended to enhance or improve the inherent proper-
ties of the polymer, including factors such as mechanical strength, thermal and 
 ultraviolet stability, and gas and vapour barrier properties (Lagaron and Lopez-
Rubio 2011). The high surface-to-volume ratio of nanofillers enhances their inher-
ent chemical and mechanical properties compared with larger-scale versions of the 
same material, whilst allowing them to disperse within polymers without introduc-
ing structural defects. For example, addition of nanoclays can enhance the oxygen 
barrier properties of plastics, which makes them particularly attractive for keeping 
food from spoiling (Lagaron and Lopez-Rubio 2011).
The addition of nanomaterials into polymers can also cut down on the need for 
large amounts of additives, for example by acting as antioxidants or  antimicrobial 
agents themselves (De Azedero 2013). In relation to plastic discarded to the envi-
ronment, a major added benefit of nanofillers is that they may also be able to reduce 
the unintended migration of additives out of polymers (de Abreu et al. 2010). 
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The migration of various polymer additives, including triclosan and diphenyl 
 butadiene from polyamide into food stimulants was found to be up to six times lower 
when nanoclays were added to the polyamide. The nanoclay particles were thought 
to slow down the rate of migration of the additives due to their layering within the 
polymer matrix, creating a tortuosity effect (Fig. 13.3) (de Abreu et al. 2010). Thus, 
new advances in nanotechnology may bring unintended benefits in terms of the 
reduced leaching of their additives and hence the environmental safety of the poly-
mers that contain them.
Table 13.5  Indicators of potential toxicity for nanoparticles contained within food packaging












Rigid, long tubes or  
fibres, high aspect ratios, 
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13.6  Conclusions and Future Work
This short account has identified some of the most widely encountered plastics in 
everyday use and illustrated some of the attempts that have been made to assess 
their potential hazards to human health. Different routes of exposure to human 
populations, both of plastic additives, micro- and nanoplastics from food items 
and from discarded debris are discussed in relation to the existing literature for 
 nanomedicines and nanocomposite packaging materials, for which an increasing 
body of knowledge exists. It is clear that our understanding of the potential con-
tamination of the human population by micro- or nanoplastics sourced from the 
environment is in its infancy, leaving many questions unanswered:
•	 Does significant bioaccumulation and trophic transfer for micro- and nanoplas-
tics occur in the environment? If so, what species are most at risk?
•	 How does ageing of plastics affect their physico-chemical properties and subse-
quent toxicity?
•	 Following ingestion, does uptake of micro- and nanoplastics occur? Do pro-
teins bind to the surface of the particles to form a protein corona? How does this 
vary for different plastic litter types and what cell types are most vulnerable to 
toxicity?
•	 What methods should we be using for locating, identifying and quantify-
ing micro- and nanoplastics in complex matrices including biological tissues? 
Techniques mentioned in this chapter include field flow fractionation, multi-
angled light scattering (MALS), inductively coupled plasma mass spectrometry 
(ICP-MS) and non-linear optical bioimaging. Further development of suitable 
methods for extracting micro- and nanoplastics from biological materials and 
for studying them in situ remains a compelling research gap for the future.
Acknowledgements TG gratefully acknowledges financial support from grants EU FP7 






Fig. 13.3  Tortuosity effect of nanoclay in limiting the diffusion of permeants through polymers 
(adapted from Ray and Okamato 2003)
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